GESTONORONE CAPROATE

GESTONORONE CAPROATE Basic information
Product Name:GESTONORONE CAPROATE
Synonyms:GESTONORONE CAPROATE;GestonoroneAcetateCaproate;Depostat (TN);17-Hydroxy-19-norpregn-4-ene-3,20-dione hexanoate;17α-Hydroxy-19-norprogesterone caproate;17α-Hydroxy-19-norprogesterone capronate;17β-Acetyl-17-hydroxyestr-4-ene-3-one hexanoate;19-Nor-17α-caproyloxy-4-pregnene-3,20-dione
CAS:1253-28-7
MF:C26H38O4
MW:414.58
EINECS:215-010-2
Product Categories:Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Steroids
Mol File:1253-28-7.mol
GESTONORONE CAPROATE Structure
GESTONORONE CAPROATE Chemical Properties
Melting point 123-124°
alpha D +13° (chloroform)
Boiling point 453.43°C (rough estimate)
density 1.11
refractive index 1.4840 (estimate)
storage temp. Refrigerator
solubility Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
form Solid
color Off-White to Pale Beige
Safety Information
MSDS Information
GESTONORONE CAPROATE Usage And Synthesis
OriginatorDepostat,Schering AG
UsesGestonorone Capronate, is a pro-drug of Gestonorone, which is a steroidal progestin. It has been shown to have accelerated body weight gain and caused the atrophy of the prostate, uterus, and seminal vesicles in rats. It is also an inhibitor of the reductive pathway of Testosterone (T155000) metabolism.
UsesGestonorone Caproate, is a pro-drug of Gestonorone, which is a steroidal progestin. It has been shown to have accelerated body weight gain and caused the atrophy of the prostate, uterus, and seminal vesicles in rats. It is also an inhibitor of the reductive pathway of Testosterone (T155000) metabolism.
DefinitionChEBI: Gestonorone caproate is an organic molecular entity.
Manufacturing Process2 Methods of producing of 17-α-hydroxyl-19-norprogesteron-17-capronate:
1. To a solution of 1.0 g 17-α-hydroxy-19-norprogesteron in 32 ml capronic acid anhydride 1.32 g p-toluesulfonate (1 mole hydrate) were added, and allowed to stand for 3 h at 37°C. To the solution 1.43 ml conc. hydrochloric acid in 143 ml methanol were added and all this also for 1 h was left under N2. Then mixture was washed with water and treated with ether. Ether extract was washed with water, and dried with Na2SO4. After that ether was distilled and residue was recrystallised with isopropyl ether. 1.1 g of 17-α-hydroxyl-19- norprogesteron-17-capronate was obtained, melting point 123°-124°C.
2. 2.0 g 3-methoxy-17α-hydroxy-17β-acetyl-δ2,5(10)-oestradien, 60 ml capronic acid anhydride, 2.6 g p-toluensulfonate and 18.0 g water were mixed and left for 6 h at room temperature. Then solution obtained was treated ether and sodium bicarbonate and washed with water. Etheral solution was dried over sodium sulfate. After distillation of ether 3.1 g 3,17α-dihydroxy- δ3,5-19-norpregnadien-3,17-dicapronate was produced.
To solution of 3.1 g 3,17α-dihydroxy-δ3,5-19-norpregnadien-3,17-dicapronate in 250 ml methanol 2.5 g conc. hydrochloric acid were added and mixture was left for 1 h. Then mixture was filtered and residue was washed. After recrystallisation with isopropyl ether 17-α-hydroxyl-19-norprogesteron-17- capronate was obtained, melting point 121°-123°C.


Therapeutic FunctionProgestin
GESTONORONE CAPROATE Preparation Products And Raw materials
Raw materialsSodium bicarbonate-->Hydrochloric acid-->HEXANOIC ANHYDRIDE
17a-Hydroxy-19-norpregn-4-ene-3,20-dione FEMA 3332 Hexanoic acid 19-NORPROGESTERONE Gestonorone Gestonoronacetat GESTONORONE CAPROATE

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.